Vision Transformer–based ultrasound AI to detect placenta accreta spectrum
Official title: Diagnostic Trial of Vision Transformer-Based End-to-End Ultrasound Artificial Intelligence Model for Assisting in the Diagnosis of Placenta Accreta Spectrum Disorders: An Investigator-Initiated Prospective Clinical Study
Run by The Third Affiliated Hospital of Guangzhou Medical University · NCT07643090 · Data updated 2026-11-12
A AI tool uses ultrasound video inputs to help see if the placenta is abnormally attached during pregnancy in women at risk.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 561 (estimated) |
| Sponsor | The Third Affiliated Hospital of Guangzhou Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | September 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT07643090 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 to 45 with gestational age 24 to 34 weeks, including those with a history of placenta previa or an anterior placenta.
✕Probably not a fit
Individuals without PAS risk factors or with ultrasound findings clearly indicating normal placentation may not benefit from this diagnostic tool.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study develops an end-to-end Vision Transformer–based AI system to analyze standardized ultrasound video sequences for prenatal PAS detection. The model is trained with postpartum confirmation data and aims to improve consistency and speed of interpretation. The study focuses on translating dynamic ultrasound into reliable diagnostic support for PAS to aid clinical decision-making.
Why it matters
Potential benefit: If successful, the AI system could improve prenatal accuracy and efficiency in diagnosing placenta accreta spectrum, potentially reducing maternal and neonatal complications through earlier, more consistent detection.
How similar studies have gone: Prior studies have shown promise for AI in ultrasound-based prenatal diagnosis, but this specific Vision Transformer–based end-to-end approach for PAS is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Pregnant women aged between 18 and 45 years; 2. Gestational age between 24 and 34 weeks; 3. Pregnant women with a history of placenta previa; 4. Pregnant women with an anterior placenta; 5. Willingness to participate in the study and provision of written informed consent. Exclusion criteria: 1. Failure to provide written informed consent; 2. Presence of severe complications that precluded continuation of pregnancy; 3. Inability to comply with study procedures for other reasons.
Where it's running
-
The Third Affiliated Hospital, Guangzhou Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Fang He, M.D, PhD
- Email: Gzhefang@gzhmu.edu.cn
- Phone: +86 13724831279
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Three conservative surgeries for placenta accreta spectrum: a comparison
Researchers compare three uterus-preserving surgical options to see which works best for placenta accreta spectrum.
-
Planned cesarean at 37 weeks versus 36 weeks for pregnancies with placenta previa and accreta
We will test whether scheduling cesarean delivery at 37 weeks instead of 36 weeks helps newborns without increasing maternal bleeding in pregnant women with placenta previa and accreta.
-
High versus low segmental hysterotomy and uterine scar defects after a first cesarean
We will test whether high or low segmental hysterotomy, with or without cross-suturing, leads to fewer uterine scar defects in people having their first cesarean.
-
Managing placenta accreta spectrum while preserving the uterus
This study is testing a new way to manage placenta accreta spectrum disorders by allowing some women to keep their uterus after delivery instead of having surgery, to see if it can be a safer option for them.
-
Outcomes of Uterine Conservation in Placenta Accreta Spectrum
This study looks at how well uterine conservation procedures work for women with placenta accreta spectrum by tracking their recovery, blood loss, and menstrual return after the surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.